QNTM
Quantum BioPharma·NASDAQ
--
--(--)
--
--(--)
QNTM fundamentals
Quantum BioPharma (QNTM) expects to report earnings on Mar 24, 2026, with estimated revenue of 0 (YoY --), and EPS at -1.0215 (YoY +63.23%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-1.0215
+63.23%
Report date
Mar 24, 2026
EPS
Actual | 27.5342 | -68.7361 | -22.8815 | -9.5744 | -9.3119 | -1.9506 | -2.6784 | -3.2666 | -0.0788 | -2.8767 | -2.7783 | -3.4235 | -3.2651 | -1.2632 | ||||||||
Forecast | -40.1767 | -9.086 | -9.3131 | -3.2757 | -3.8909 | -2.7686 | -0.7784 | -0.6248 | -0.1697 | -2.6589 | -1.0215 | |||||||||||
Surprise | 0.00% | 0.00% | -71.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +78.53% | +71.24% | +0.28% | +97.97% | -3.90% | -256.92% | -447.94% | -1824.04% | +52.49% | 0.00% |
Revenue
Actual | -- | 6.14B | 0 | -- | -- | -- | -- | -- | -- | -- | -- | 0 | -- | -- | -- | 0 | 0 | 0 | 2.09M | 0 | 0 | -- |
Forecast | -- | -- | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 924.32K | 2.09M | 2.89M | 889.59K | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +0.12% | -100.00% | -100.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Quantum BioPharma's earnings call?What factors drove the changes in Quantum BioPharma's revenue and profit?What is the revenue and EPS growth rate for Quantum BioPharma year over year?Did Quantum BioPharma beat or miss consensus estimates last quarter?What were the key takeaways from Quantum BioPharma’s earnings call?What is Quantum BioPharma's gross profit margin?What is Quantum BioPharma's latest dividend and current dividend yield?What is the market's earnings forecast for Quantum BioPharma next quarter?
